(MedPage Today) — Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new standard of care.
Among 490…

Read the full article on medpagetoday.com